On 21 November 2012, representatives from 65 Member States of the World Health Organization (WHO) and the European Union agreed to promote the strengthening of national regulatory capacity to combat substandard/spurious/falsely-labelled/falsified/counterfeit medical products. They further agreed to identify actions and behaviours that result in substandard/spurious/falsely-labelled/falsified/counterfeit medical products in order to secure access to high-quality, safe medicines.